1. Alternate treatment allocation constitutes a random method when the ®rst subject is randomly assigned to the treatment or control groups. Subsequent allocation using an alternate method is the basis of the so-called systematic sampling, and as referred to by Levy and Lemeshow (1991) , this is the most widely used method in sampling. In our study we applied the method described above. Therefore, there is no methodological shortcoming due to this aspect. 2. Although our trial suffered from large losses to followup, they were`apparently unbiased', as commented by Dr Kramer (1993) and explained in our report. Large losses to follow-up were foreseen and considered when designing the test. 3. Dr Kramer thinks that Tables 5 and 6 of our report are apparently erroneous because they showed virtually identical data in the background and outcome data for noncompliers in the two study groups. We believe that this argument does not reveal a shortcoming for two reasons. Firstly, because we also showed that background data of noncompliers (Table 5) do not differ from compliers in the two study groups (Table 7) . Secondly, because this discussion is about the possible effect of micronutrients in the compliers; the observed outcome in the noncompliers is not the central part of the results presented and they constituted just 10% of each study group.
Although Dr Kramer reversed the original study groups with honourable intention, we think that the above arguments justify looking at the results of our study as they were originally presented. We conclude that Dr Kramer is right when he asks for more evidence. New trials are needed to show consistent results as a criterion to prove causality.
